Literature DB >> 19716787

Loss of human ribosomal gene CpG methylation enhances cryptic RNA polymerase II transcription and disrupts ribosomal RNA processing.

Thérèse Gagnon-Kugler1, Frédéric Langlois, Victor Stefanovsky, Frédéric Lessard, Tom Moss.   

Abstract

Epigenetic methyl-CpG silencing of the ribosomal RNA (rRNA) genes is thought to downregulate rRNA synthesis in mammals. In contrast, we now show that CpG methylation in fact positively influences rRNA synthesis and processing. Human HCT116 cells, inactivated for DNMT1 and DNMT3b or treated with aza-dC, lack CpG methylation and reactivate a large fraction of normally silent rRNA genes. Unexpectedly, these cells display reduced rRNA synthesis and processing and accumulate unprocessed 45S rRNA. Reactivation of the rRNA genes is associated with their cryptic transcription by RNA polymerase II. Ectopic expression of cryptic rRNA gene transcripts recapitulates the defects associated with loss of CpG methylation. The data demonstrate that rRNA gene silencing prevents cryptic RNA polymerase II transcription of these genes. Lack of silencing leads to the partial disruption of rRNA synthesis and rRNA processing, providing an explanation for the cytotoxic effects of loss of CpG methylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716787     DOI: 10.1016/j.molcel.2009.07.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  54 in total

1.  Nucleolar Enrichment of Brain Proteins with Critical Roles in Human Neurodevelopment.

Authors:  Lukasz P Slomnicki; Agata Malinowska; Michal Kistowski; Antoni Palusinski; Jing-Juan Zheng; Mari Sepp; Tonis Timmusk; Michal Dadlez; Michal Hetman
Journal:  Mol Cell Proteomics       Date:  2016-04-06       Impact factor: 5.911

2.  A model for the topology of active ribosomal RNA genes.

Authors:  Serguei Denissov; Frédéric Lessard; Christine Mayer; Victor Stefanovsky; Marc van Driel; Ingrid Grummt; Tom Moss; Hendrik G Stunnenberg
Journal:  EMBO Rep       Date:  2011-02-18       Impact factor: 8.807

3.  The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation.

Authors:  Moshe Szyf
Journal:  Toxicol Sci       Date:  2011-02-04       Impact factor: 4.849

4.  Using a Multi-Stage hESC Model to Characterize BDE-47 Toxicity during Neurogenesis.

Authors:  Hao Chen; Helia Seifikar; Nicholas Larocque; Yvonne Kim; Ibrahim Khatib; Charles J Fernandez; Nicomedes Abello; Joshua F Robinson
Journal:  Toxicol Sci       Date:  2019-06-07       Impact factor: 4.849

5.  Construction of synthetic nucleoli and what it tells us about propagation of sub-nuclear domains through cell division.

Authors:  Alice Grob; Brian McStay
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.

Authors:  M Monika Belickova; Michaela Dostalova Merkerova; Hana Votavova; Jan Valka; Jitka Vesela; Barbora Pejsova; Hana Hajkova; Jiri Klema; Jaroslav Cermak; Anna Jonasova
Journal:  Int J Hematol       Date:  2016-07-14       Impact factor: 2.490

Review 7.  The Epigenetic Pathways to Ribosomal DNA Silencing.

Authors:  Rakesh Srivastava; Rashmi Srivastava; Seong Hoon Ahn
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

8.  SUMOylation down-regulates rDNA transcription by repressing expression of upstream-binding factor and proto-oncogene c-Myc.

Authors:  Yu Peng; Zhenxing Wang; Zhiqiang Wang; Fang Yu; Jiwen Li; Jiemin Wong
Journal:  J Biol Chem       Date:  2019-11-06       Impact factor: 5.157

9.  Novel sub-cellular localizations and intra-molecular interactions may define new functions of Mixed Lineage Leukemia protein.

Authors:  Amit Mahendra Karole; Swathi Chodisetty; Aamir Ali; Nidhi Kumari; Shweta Tyagi
Journal:  Cell Cycle       Date:  2018-12-10       Impact factor: 4.534

10.  Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.

Authors:  Aparna Raval; Kunju J Sridhar; Shripa Patel; Brit B Turnbull; Peter L Greenberg; Beverly S Mitchell
Journal:  Blood       Date:  2012-10-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.